Valuation: ResMed Inc.

Market Cap 31.73B 27.41B 25.79B 23.44B 44.08B 3,040B 44.73B 302B 119B 1,521B 119B 117B 5,065B P/E 2027 *
19.1x
P/E 2028 * 17.2x
Enterprise Value 30.78B 26.59B 25.02B 22.74B 42.76B 2,950B 43.39B 293B 115B 1,475B 116B 113B 4,914B EV / Sales 2027 *
5.3x
EV / Sales 2028 * 4.86x
Free-Float
37.56%
Yield 2027 *
1.21%
Yield 2028 * 1.35%
1 day+29.44%
1 week+37.02%
Current month+37.02%
1 month+37.02%
3 months+29.29%
6 months-17.77%
Current year-14.29%
1 week 22.48
Extreme 22.48
22.91
1 month 22.48
Extreme 22.48
22.91
Current year 11.85
Extreme 11.85
37.91
1 year 11.85
Extreme 11.85
37.91
3 years 11.85
Extreme 11.85
37.91
5 years 1.9
Extreme 1.9
37.91
10 years 0
Extreme 0
37.91
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Change 5-day change 1-year change 3-year change Capi.($)
+29.44%+37.02% - - 31.73B
+0.60%-2.64%+20.82%+10.64% 218B
-1.51%-3.79%-4.51%-20.62% 140B
+0.22%-2.50%-18.72%+36.80% 138B
-1.87%-1.41%-51.02%+0.56% 73.14B
+0.19%-2.86%+16.19%+18.80% 52.44B
+1.18%-0.33%-16.45%-13.29% 50.85B
-0.01%-0.70%+25.64%+24.48% 41.92B
-1.59%-3.31%+38.65%+48.61% 39.42B
+0.36%-0.16%-0.74%+6.25% 32.81B
Average +2.70%-1.80%+1.09%+12.47% 87.43B
Weighted average by Cap. +0.93%-2.30%+0.21%+10.18%

Financials

2027 *2028 *
Net sales 5.81B 5.02B 4.72B 4.29B 8.07B 557B 8.19B 55.4B 21.71B 279B 21.82B 21.35B 928B 6.19B 5.34B 5.03B 4.57B 8.6B 593B 8.72B 58.98B 23.11B 297B 23.23B 22.73B 988B
Net income 1.63B 1.41B 1.32B 1.2B 2.26B 156B 2.3B 15.52B 6.08B 78.04B 6.11B 5.98B 260B 1.78B 1.54B 1.45B 1.32B 2.47B 171B 2.51B 16.98B 6.65B 85.36B 6.69B 6.54B 284B
Net Debt -949M -819M -771M -701M -1.32B -90.89B -1.34B -9.04B -3.54B -45.46B -3.56B -3.48B -151B -1.63B -1.41B -1.33B -1.21B -2.27B -157B -2.3B -15.57B -6.1B -78.28B -6.13B -6B -261B
Logo ResMed Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
11,370
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
219.98USD
Average target price
247.20USD
Spread / Average Target
+12.37%

Quarterly revenue - Rate of surprise